GTH(Delisted)
Genetron Holdings·NASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About GTH
Genetron Holdings Limited
A leading precision oncology platform company in China that provides precision oncology medicine for the treatment of cancer
--
04/09/2018
06/19/2020
NASDAQ Stock Exchange
993
12-31
Depository Receipts (Ordinary Shares)
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District, Beijing, 102206, People’s Republic of China
Laboratory Development and Testing Services
Genetron Holdings Limited was incorporated in the Cayman Islands as an exempted limited liability company on 9 April 2018 under the Cayman Islands Companies Law (2018 Revision). It is a global cutting-edge cancer precision medicine company, focusing on the research and application of cancer genomics, providing products and services covering the whole cycle of cancer, such as early cancer screening, medication guidance, prognosis and monitoring, and drug research and development services. It is committed to applying innovative genomics technology to cancer-related diagnosis and treatment, and ultimately defeating cancer.
Company Financials
EPS
GTH has released its 2022 Q2 earnings. EPS was reported at -0.37, versus the expected 0, missing expectations. The chart below visualizes how GTH has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
